Scope Biosciences

About:

Scope Biosciences is a on-site development platform technology specializing in the development of molecular diagnostics using CRISPR-Cas.

Website: https://www.scopebio.com

Twitter/X: scope_bio

Top Investors: Genome Diagnostics

Description:

Scope Biosciences is a company, specializing in the development of molecular diagnostics using CRISPR-Cas. It is a spin-off of Wageningen University & Research .

Total Funding Amount:

1M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Wageningen, Gelderland, The Netherlands

Founded Date:

2019-01-01

Contact Email:

info(AT)scopebio.com

Founders:

Bart Scholten, Jurre Steens, Math Kohnen, Niek Savelkoul, Stijn Prinsen, Wil Hazenberg

Number of Employees:

11-50

Last Funding Date:

2021-10-29

IPO Status:

Private

Industries: